These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9. Lonsdale R; Houghton KT; Żurek J; Bathelt CM; Foloppe N; de Groot MJ; Harvey JN; Mulholland AJ J Am Chem Soc; 2013 May; 135(21):8001-15. PubMed ID: 23641937 [TBL] [Abstract][Full Text] [Related]
5. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations. Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072 [TBL] [Abstract][Full Text] [Related]
6. The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution. Wester MR; Yano JK; Schoch GA; Yang C; Griffin KJ; Stout CD; Johnson EF J Biol Chem; 2004 Aug; 279(34):35630-7. PubMed ID: 15181000 [TBL] [Abstract][Full Text] [Related]
7. Exploration of the binding of proton pump inhibitors to human P450 2C9 based on docking and molecular dynamics simulation. Shi R; Li J; Cao X; Zhu X; Lu X J Mol Model; 2011 Aug; 17(8):1941-51. PubMed ID: 21120554 [TBL] [Abstract][Full Text] [Related]
8. Assessment of arginine 97 and lysine 72 as determinants of substrate specificity in cytochrome P450 2C9 (CYP2C9). Davies C; Witham K; Scott JR; Pearson A; DeVoss JJ; Graham SE; Gillam EM Drug Metab Dispos; 2004 Apr; 32(4):431-6. PubMed ID: 15039296 [TBL] [Abstract][Full Text] [Related]
9. Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19. Reynald RL; Sansen S; Stout CD; Johnson EF J Biol Chem; 2012 Dec; 287(53):44581-91. PubMed ID: 23118231 [TBL] [Abstract][Full Text] [Related]
10. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9. Cojocaru V; Winn PJ; Wade RC Curr Drug Metab; 2012 Feb; 13(2):143-54. PubMed ID: 22208529 [TBL] [Abstract][Full Text] [Related]
11. Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach. Tarcsay A; Kiss R; Keseru GM J Comput Aided Mol Des; 2010 May; 24(5):399-408. PubMed ID: 20361237 [TBL] [Abstract][Full Text] [Related]
12. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro. Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056 [TBL] [Abstract][Full Text] [Related]
13. On the human CYP2C9*13 variant activity reduction: a molecular dynamics simulation and docking study. Zhou YH; Zheng QC; Li ZS; Zhang Y; Sun M; Sun CC; Si D; Cai L; Guo Y; Zhou H Biochimie; 2006 Oct; 88(10):1457-65. PubMed ID: 16740353 [TBL] [Abstract][Full Text] [Related]
14. Multiple molecular dynamics simulations of human p450 monooxygenase CYP2C9: the molecular basis of substrate binding and regioselectivity toward warfarin. Seifert A; Tatzel S; Schmid RD; Pleiss J Proteins; 2006 Jul; 64(1):147-55. PubMed ID: 16639745 [TBL] [Abstract][Full Text] [Related]
15. Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen. Klose TS; Ibeanu GC; Ghanayem BI; Pedersen LG; Li L; Hall SD; Goldstein JA Arch Biochem Biophys; 1998 Sep; 357(2):240-8. PubMed ID: 9735164 [TBL] [Abstract][Full Text] [Related]
16. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. Skopalík J; Anzenbacher P; Otyepka M J Phys Chem B; 2008 Jul; 112(27):8165-73. PubMed ID: 18598011 [TBL] [Abstract][Full Text] [Related]
17. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II. Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF Curr Drug Metab; 2009 Dec; 10(10):1127-50. PubMed ID: 20167000 [TBL] [Abstract][Full Text] [Related]
18. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I. Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF Curr Drug Metab; 2009 Dec; 10(10):1075-126. PubMed ID: 20167001 [TBL] [Abstract][Full Text] [Related]
19. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid. Melet A; Assrir N; Jean P; Pilar Lopez-Garcia M; Marques-Soares C; Jaouen M; Dansette PM; Sari MA; Mansuy D Arch Biochem Biophys; 2003 Jan; 409(1):80-91. PubMed ID: 12464247 [TBL] [Abstract][Full Text] [Related]